Montmoro May Shield Eyes from Diabetes

An American study has shown that the drug tirzepatide, used for diabetes treatment and weight loss, reduces the risk of developing eye complications associated with diabetes, particularly retinopathy, after monitoring groups of patients for one year. The results indicated a roughly 30% decrease in the risk of advanced stages of the disease and a 40% reduction in the need for specialized treatments. It is believed that the drug's mechanism of action helps improve the body's insulin response and decrease pressure on the blood vessels in the eye.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل